# Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

> **NCT01751555** · PHASE4 · COMPLETED · sponsor: **National Center for AIDS/STD Control and Prevention, China CDC** · enrollment: 100 (actual)

## Conditions studied

- Hiv

## Interventions

- **DRUG:** Regimen:TDF+3TC+EFV

## Key facts

- **NCT ID:** NCT01751555
- **Lead sponsor:** National Center for AIDS/STD Control and Prevention, China CDC
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01751555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01751555, "Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01751555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*